Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on Apr 19, 2024 6:39pm
91 Views
Post# 35999043

RE:RE:RE:RE:RE:RE:RE:RE:RE:CEO said, "we are undervalued". Okay, so how what is an

RE:RE:RE:RE:RE:RE:RE:RE:RE:CEO said, "we are undervalued". Okay, so how what is an I know that M&A isn't needed since if any company 'needs' M&A to survive and thrive then the company is not healthy.

I also know M&A is not needed as the company themselves have indicated time and again that they have right sized the SKUs and have strong partnerships in important jurisdictions in the world, partnerships that presumably would be able to leverage a product set LABS already has (ie. why would any partner sign up to be a partner if the products they want to partner on aren't available with the partner they want).

Wasting money on another M&A activity at this point is meaningless when they themselves have stated they have all the need to grow the business.  Inorganic growth can come once and only once they have executed with what they have now.

A share buyback with the money is the greatest gift they can give shareholders right now.  If they want M&A, let them do it once they're profitable and have money from operations to spend.  The need not empire build any longer, that can come later.

<< Previous
Bullboard Posts
Next >>